Canine Footpad Hyperkeratosis: A Lesion-Directed Diagnostic Workup

Bottom line

Footpad hyperkeratosis is a lesion pattern; differentials include cornification disorders, hepatocutaneous syndrome, and pemphigus.[1]

The practical workup should distinguish pad-only keratin proliferation from inflammatory pododermatitis and systemic disease before selecting treatment. Juvenile onset can justify a genetic investigation, but gene findings must be interpreted at the level of the specific breed and phenotype, not generalized across dogs.

Map the phenotype before sampling

Build a lesion map separating pad surface, pad margins, interdigital haired skin, nail folds, and nonpedal lesions. Record onset, progression, gait impairment, family history, diet and supplements, topical exposure, vaccination history, travel, and prior treatment. Dermatologic diagnosis depends on a detailed history, complete examination, and appropriate testing; systemic signs can justify CBC, chemistry, and urinalysis.[2]

As a clinical organizing framework, branch into: pad-dominant disease without substantial inflammation; erosive or crusting disease with extrapedal lesions; and inflammatory interdigital disease with nodules or drainage. A dog may occupy more than one branch. Do not let conspicuous keratin obscure a painful fissure or concurrent infection.

Cytology and culture for inflammatory pedal disease

For inflamed, exudative, or interdigital lesions, baseline dermatologic investigation includes cytology and deep scrapings or hair plucks. Culture and susceptibility testing can guide antimicrobial selection once pedal pyoderma is confirmed; deep nodules and draining tracts favor tissue culture rather than superficial swabs.[3]

This is a concurrent-disease pathway, not proof that bacteria caused the original pad thickening. Use the canine allergic skin disease workup when the history and distribution warrant that branch. The amoxicillin-clavulanate reference addresses prescribing considerations separately; this hub does not establish an indication for that drug.

Biopsy: preserve the lesion and ask a specific question

Biopsy is appropriate for severe, unusual, or treatment-refractory skin disease. Do not clean away surface pathology before histologic sampling; submit representative primary lesions from different sites and provide the clinical distribution and differential list.[2]

In the reported DSG1-associated Rottweiler, footpad biopsies were used to exclude inflammatory and infectious causes. Histology showed villous orthokeratotic hyperkeratosis without significant inflammation.[4] That pattern documents cornification abnormality but should not be used to assign a genotype from a biopsy alone.

If skin crusting raises zinc-responsive dermatosis as a differential, interpret biopsy with signalment and diet: the published review describes diagnosis through history, clinical signs, and skin biopsy.[5] Avoid substituting an unstructured supplement trial for a coherent differential workup.

Screen the metabolic branch when lesions extend beyond pads

Superficial necrolytic dermatitis can cause severe pedal lesions and extra-pedal disease. Abdominal ultrasonography may demonstrate a honeycomb hepatic pattern; skin histopathology shows superficial parakeratosis, epidermal edema, and basal hyperplasia.[6]

For a compatible presentation, integrate clinicopathologic assessment, abdominal imaging, and representative skin sampling. Plan these in parallel when pain or systemic compromise makes a prolonged sequence inappropriate. Do not interpret an ultrasound pattern in isolation or equate all hyperkeratotic pads with liver disease.

Genetic testing: match the assay to the evidence

FAM83G:c.155G>C was associated with autosomal-recessive hereditary footpad hyperkeratosis in Irish Terriers and Kromfohrländers.[7] A homozygous DSG1 frameshift variant was reported in a Rottweiler with severe juvenile pad disease and subsequent allergic and infectious skin manifestations; the authors describe causality as suggested by comparative evidence.[4]

Rietmann and colleagues reported a de novo heterozygous GJB6:c.223C>T candidate variant in a Labrador Retriever with paw-pad hyperkeratosis.[8] This is a case-level finding, not evidence for a universal Labrador screening panel. Clarify assay availability and what a negative result excludes; retain tissue-based and acquired-disease differentials when the tested variant is absent.

Management endpoints and reassessment

Familial hyperkeratosis is managed supportively with softening care and treatment of secondary pyoderma.[1]

Define separate endpoints for comfort, fissure healing, infection control, and keratin recurrence. Reassess the diagnosis if pad growth accelerates, lesions emerge elsewhere, or control of a documented secondary problem does not restore function.

Frequently Asked Questions

Does footpad hyperkeratosis identify a single disease?

No. Consider cornification disorders, hepatocutaneous syndrome, and pemphigus.[1]

Which findings support a familial FAM83G-associated phenotype?

Compatible pad disease in an Irish Terrier or Kromfohrländer warrants consideration of the reported FAM83G variant.[7]

Should draining pedal lesions be cultured with a surface swab?

For suspected deep pedal pyoderma, tissue culture is preferred over superficial swabs.[3]

Should crusts be removed before histopathology?

No. Preserve surface pathology and sample representative primary lesions.[2]

What supports superficial necrolytic dermatitis rather than uncomplicated keratin overgrowth?

Compatible skin histopathology and the metabolic workup are more informative than pad appearance alone; a honeycomb hepatic ultrasound pattern can support the investigation.[6]

Does the GJB6 Labrador report establish a breed-wide test?

No. It identifies a candidate de novo variant in an affected Labrador, not a breed-wide validation study.[8]